Boston Scientific Receives FDA Clearance for Asurys Fluid Management System
Device is designed to regulate irrigation and intrarenal pressure during endoscopic urologic procedures
Device is designed to regulate irrigation and intrarenal pressure during endoscopic urologic procedures
The CTA-based system creates a patient-specific 3D map of the cardiac conduction system to support planning and guidance during procedures such as TAVR and conduction system pacing.
The system features a compact footprint and is designed for whole-body imaging in neonatal care settings.
The system is designed to give surgeons a clear, real-time view of critical anatomy and planned trajectories.
The removal is tied to incorrect software installations that could result in inaccurate flow rates and user confusion during clinical use.
Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
The U.S. FDA has proposed banning electrical stimulation devices for self-injurious or aggressive behavior due to significant risks, marking the second attempt at prohibition, with implications including potential treatment transitions for users and a thorough review of updated evidence and expert opinions.